
Nutriband CEO Outlines 2025 Achievements and 2026 Outlook in Shareholder Letter
Nutriband Inc. CEO Gareth Sheridan detailed the company's 2025 milestones, including progress on its abuse-deterrent fentanyl patch AVERSA™, and provided perspective on 2026 priorities focused on shareholder value and commercialization.
Read full story


























